Advertisement
Oneview Healthcare PLC

Oneview Healthcare PLC Fundamental Analysis

ONE.AXASX
HealthcareMedical - Healthcare Information Services
$0.13
$0.01(10.34%)
Australian Market opens in 15h 24m
Advertisement

Oneview Healthcare PLC Fundamental Analysis

Oneview Healthcare PLC (ONE.AX) shows weak financial fundamentals with a PE ratio of -5.24, profit margin of -1.05%, and ROE of -2.27%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.45

Areas of Concern

ROE-2.27%
Operating Margin-92.06%
Cash Position4.28%
We analyze ONE.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -352.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-352.4/100

We analyze ONE.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ONE.AX struggles to generate sufficient returns from assets.

ROA > 10%
-81.61%

Valuation Score

Excellent

ONE.AX trades at attractive valuation levels.

PE < 25
-5.24
PEG Ratio < 2
-0.45

Growth Score

Weak

ONE.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ONE.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.30
Current Ratio > 1
1.30

Profitability Score

Weak

ONE.AX struggles to sustain strong margins.

ROE > 15%
-226.75%
Net Margin ≥ 15%
-1.05%
Positive Free Cash Flow
No

Key Financial Metrics

Is ONE.AX Expensive or Cheap?

P/E Ratio

ONE.AX trades at -5.24 times earnings. This suggests potential undervaluation.

-5.24

PEG Ratio

When adjusting for growth, ONE.AX's PEG of -0.45 indicates potential undervaluation.

-0.45

Price to Book

The market values Oneview Healthcare PLC at 17.86 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

17.86

EV/EBITDA

Enterprise value stands at -7.23 times EBITDA. This is generally considered low.

-7.23

How Well Does ONE.AX Make Money?

Net Profit Margin

For every $100 in sales, Oneview Healthcare PLC keeps $-1.05 as profit after all expenses.

-1.05%

Operating Margin

Core operations generate -92.06 in profit for every $100 in revenue, before interest and taxes.

-92.06%

ROE

Management delivers $-2.27 in profit for every $100 of shareholder equity.

-2.27%

ROA

Oneview Healthcare PLC generates $-81.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

-81.61%

Following the Money - Real Cash Generation

Operating Cash Flow

Oneview Healthcare PLC generates limited operating cash flow of $-9.82M, signaling weaker underlying cash strength.

$-9.82M

Free Cash Flow

Oneview Healthcare PLC generates weak or negative free cash flow of $-9.89M, restricting financial flexibility.

$-9.89M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

ONE.AX converts -11.55% of its market value into free cash.

-11.55%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.45

vs 25 benchmark

P/B Ratio

Price to book value ratio

17.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.19

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.30

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.27

vs 25 benchmark

ROA

Return on assets percentage

-0.82

vs 25 benchmark

ROCE

Return on capital employed

-1.96

vs 25 benchmark

How ONE.AX Stacks Against Its Sector Peers

MetricONE.AX ValueSector AveragePerformance
P/E Ratio-5.2429.58 Better (Cheaper)
ROE-226.75%391.00% Weak
Net Margin-104.78%-11427.00% (disorted) Weak
Debt/Equity0.300.77 Strong (Low Leverage)
Current Ratio1.305.10 Neutral
ROA-81.61%-260.00% (disorted) Weak

ONE.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Oneview Healthcare PLC's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ